OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review on recent development of quinoline for anticancer activities
Mohan Ilakiyalakshmi, Ayyakannu Arumugam Napoleon
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 11, pp. 104168-104168
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Quinolone Derivatives as Anticancer Agents: Importance in Medicinal Chemistry
Nursyuhada Azzman, Sirajudheen Anwar, Wan Ahmad Syazani Mohamed, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 13, pp. 1134-1157
Closed Access | Times Cited: 1

Expanding potential of quinoline hydrazide/hydrazone derivatives as anticancer agents
Sangeeta Verma, Sukhbir Lal, Rakesh Narang
Future Medicinal Chemistry (2024) Vol. 16, Iss. 13, pp. 1283-1286
Closed Access | Times Cited: 1

Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)
Mohammad Mahboubi‐Rabbani, Amir Hossein Abdolghaffari, Mahsa Ghesmati, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 733-757
Closed Access | Times Cited: 1

Novel Quinolin-4-ylcarbonylhydrazine Having N-(3-Arylacryloyl) Moiety: Design, Synthesis and Biological Evaluation as Potential Cytotoxic Agents against MDA-MB-231 via Tubulin Assembly Inhibition
Hany M. Abd El‐Lateef, Tahani H. Alharbi, Eman Fayad, et al.
Journal of Molecular Structure (2024) Vol. 1321, pp. 140214-140214
Closed Access | Times Cited: 1

Stephania tetrandra and Its Active Compound Coclaurine Sensitize NSCLC Cells to Cisplatin through EFHD2 Inhibition
Shu-Yu Hu, Tsai-Hui Lin, Chung‐Yu Chen, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1356-1356
Open Access | Times Cited: 1

New 5,6,7,8‐Tetrahydro‐isoquinolines Bearing 2‐Nitrophenyl Group Targeting RET Enzyme: Synthesis, Anticancer Activity, Apoptotic Induction and Cell Cycle Arrest
Abdelreheem Abdelfatah Saddik, Etify A. Bakhite, Reda Hassanien, et al.
Chemistry & Biodiversity (2024)
Closed Access | Times Cited: 1

Design, synthesis, biological evaluation and multi spectroscopic studies of novel 2-styrylquinoline-carboxamide derivatives as potential DNA intercalating anticancer agents
Negar Omidkhah, Amirhosein Gheisari, Sara Rahimzadeh Oskuei, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 108098-108098
Closed Access | Times Cited: 1

Anti-proliferative activity of nitroquinolone fused acylhydrazones as non-small cell human lung cancer agents
Vandana Nandakumar, Sundarasamy Amsaveni, Kaviyarasu Adhigaman, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1331-1343
Closed Access | Times Cited: 4

Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents: in vitro and in silico approach
Abhijit D. Shinde, Yogesh Nandurkar, Swapnil Bhalekar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 3, pp. 1191-1207
Closed Access | Times Cited: 4

Novel 1,2,3-Triazole-Containing Quinoline–Benzimidazole Hybrids: Synthesis, Antiproliferative Activity, In Silico ADME Predictions, and Docking
Luka Krstulović, Katarina Mišković Špoljarić, Vesna Rastija, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6950-6950
Open Access | Times Cited: 4

Synthesis Anticonvulsant and Cytotoxic Evaluation of Benzimidazole-Quinoline Hybrids Schiff Base Analogs
Devleena Tiglani, Salahuddin Salahuddin, Avijit Mazumder, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 2, pp. 960-980
Open Access | Times Cited: 4

Design, Synthesis and Bioevaluation of Novel Trifluoromethylquinoline Derivatives As Tubulin Polymerization Inhibitors
Sisi Zhang, Min Mo, Mengfan Lv, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 21, pp. 1967-1986
Closed Access | Times Cited: 3

Lipophilicity and ADMET Analysis of Quinoline-1,4-quinone Hybrids
Monika Kadela-Tomanek, Maria Jastrzębska, Elwira Chrobak, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 34-34
Open Access | Times Cited: 5

Preparation of Novel Chitosan Oligosaccharide Quaternary Ammonium Derivatives Bearing Quinoline with Antioxidative and Antibacterial Activities
Linqing Wang, Jingjing Zhang, Xiguang Liu, et al.
Starch - Stärke (2023) Vol. 75, Iss. 9-10
Closed Access | Times Cited: 2

Accessing 2‐Aryl Quinolines via Acceptorless Dehydrogenation and Transfer Hydrogenation Under Base and Solvent‐Free Reaction Conditions
M. Vageesh, P. Hima, R. Prasanna, et al.
ChemistrySelect (2023) Vol. 8, Iss. 45
Closed Access | Times Cited: 2

Synthesis, Antioxidant, and Anticancer Studies of New 1,3,4‐Oxadiazole Derivatives Linked to Benzoquinoline
Ahmed A. Fadda, Eslam R. El‐Sawy, T. A. Zidan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 28
Closed Access

A Review of Recent Progress on the Anticancer Activity of Heterocyclic Compounds
Beena Negi, Aarshiya Kwatra
SynOpen (2024) Vol. 08, Iss. 03, pp. 185-210
Open Access

Design, Synthesis and Anti‐Cancer Evaluation of Quinoline‐1,2,4‐triazine Hybrids
Chang‐E Dong, Cong Qi, Rui‐Li, et al.
ChemistrySelect (2024) Vol. 9, Iss. 33
Closed Access

Unraveling the Antidiabetic Effect of Alternantera brasiliana (L.) Kuntze: A Combined in Vitro and in Vivo Approach
Kolade O. Faloye, Funmilayo Gladys Famuyiwa, Esther A. Olanudun, et al.
Natural Product Communications (2024) Vol. 19, Iss. 10
Open Access

Quinoline- rhenium(I) tricarbonyl complexes: synthesis, spectral characterization and antiproliferative activity on T-cell lymphoma
Martina Piškor, Ivan Ćorić, Berislav Perić, et al.
Journal of Inorganic Biochemistry (2024) Vol. 262, pp. 112770-112770
Closed Access

NOVEL HYBRIDS OF QUINOLINE LINKED PYRIMIDINE DERIVATIVES AS CYCLOOXYGENASE INHIBITORS: MOLECULAR DOCKING, ADMET STUDY, AND MD SIMULATION
K DEEPTHI, Manjunatha S. Katagi, J. Fernandes, et al.
International Journal of Applied Pharmaceutics (2024), pp. 147-157
Open Access

Scroll to top